Innovative strategies for adverse karyotype acute myeloid leukemia.

Abstract excerpt

PURPOSE OF REVIEW: Adverse karyotype acute myeloid leukemia is a disease particularly of older patients, but also observed in younger patients. Despite all efforts, standard chemotherapy is still generally applied in fit patients, as already for decades, and for nearly all different subtypes of acute myeloid leukemia. Lack of more specifically targeted therapy and the often older age of the patients are...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Abnormal Karyotype
• Share to Antineoplastic Combined Chemotherapy Protocols
• Share to Clinical Trials as Topic